Breast cancer rapid diagnostic test MammaTyper®

for womenprogesteronelaboratory

Precise determination of HER2, ER, PR and Ki-67 in one assay Definitive breast cancer subtyping for confident treatment decisions Easy-to-use, quantitative and observer-independent testing Fast turnaround time and results within the same day CE-marked IVD RT-qPCR assay for most commonly available cyclers MammaTyper® precisely quantifies expression of HER2, ER, PR and Ki-67 mRNA MammaTyper® is a molecular diagnostic test for quantitative determination of the four key biomarkers used in the subtyping of breast cancer. Human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR) and the marker of proliferation Ki-67 are key biomarkers in the evaluation of breast cancer tumours. The combination of biomarker results allows the assessment of the different St. Gallen Breast Cancer subtypes which are key parameters for treatment decisions. More details MammaTyper® is an easy-to-use test for any pathology laboratory, delivering precise results within 6 hours. RNA extraction Use of RNA FFPE sample extraction kit according to IFU or validated commercial RNA extraction systems is recommended. Preparation of mastermixes and distribution on 96 well plate. Analysis of up to 8 patient samples per run. Data processing and reporting Convenient MammaTyper® Report Generator software: Export of mRNA expression data. Calculation and assessment of results.